These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20633117)

  • 101. N-acetylserotonin and aging-associated cognitive impairment and depression.
    Oxenkrug G; Ratner R
    Aging Dis; 2012 Aug; 3(4):330-8. PubMed ID: 23185714
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Interferon-gamma - Inducible Inflammation: Contribution to Aging and Aging-Associated Psychiatric Disorders.
    Oxenkrug G
    Aging Dis; 2011 Dec; 2(6):474-86. PubMed ID: 22396896
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Extension of life span of Drosophila melanogaster by the inhibitors of tryptophan-kynurenine metabolism.
    Oxenkrug GF; Navrotskaya V; Voroboyva L; Summergrad P
    Fly (Austin); 2011; 5(4):307-9. PubMed ID: 22041575
    [TBL] [Abstract][Full Text] [Related]  

  • 104. MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co-substrate.
    Boutin JA; Marcheteau E; Hennig P; Moulharat N; Berger S; Delagrange P; Bouchet JP; Ferry G
    J Pineal Res; 2008 Nov; 45(4):524-31. PubMed ID: 18826489
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3.
    Mailliet F; Ferry G; Vella F; Thiam K; Delagrange P; Boutin JA
    FEBS Lett; 2004 Dec; 578(1-2):116-20. PubMed ID: 15581627
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Involvement of dopamine D1 receptors and alpha1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test.
    Hirano S; Miyata S; Onodera K; Kamei J
    Eur J Pharmacol; 2007 May; 562(1-2):72-6. PubMed ID: 17328889
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme.
    Mailliet F; Ferry G; Vella F; Berger S; Cogé F; Chomarat P; Mallet C; Guénin SP; Guillaumet G; Viaud-Massuard MC; Yous S; Delagrange P; Boutin JA
    Biochem Pharmacol; 2005 Dec; 71(1-2):74-88. PubMed ID: 16293234
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Quinone reductase 2 and antidepressant effect of melatonin derivatives.
    Oxenkrug GF; Bachurin SO; Prakhie IV; Zefirov NS
    Ann N Y Acad Sci; 2010 Jun; 1199():121-4. PubMed ID: 20633117
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance.
    Tan DX; Manchester LC; Terron MP; Flores LJ; Tamura H; Reiter RJ
    J Pineal Res; 2007 Nov; 43(4):317-20. PubMed ID: 17910598
    [TBL] [Abstract][Full Text] [Related]  

  • 110. NRH:quinone reductase 2: an enzyme of surprises and mysteries.
    Vella F; Ferry G; Delagrange P; Boutin JA
    Biochem Pharmacol; 2005 Dec; 71(1-2):1-12. PubMed ID: 16253210
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice.
    Cryan JF; Mombereau C; Vassout A
    Neurosci Biobehav Rev; 2005; 29(4-5):571-625. PubMed ID: 15890404
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Is There Sufficient Evidence that the Melatonin Binding Site
    Boutin JA; Ferry G
    J Pharmacol Exp Ther; 2019 Jan; 368(1):59-65. PubMed ID: 30389722
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Quinone reductase 2 as a promising target of melatonin therapeutic actions.
    Boutin JA
    Expert Opin Ther Targets; 2016; 20(3):303-17. PubMed ID: 26465080
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Melatonin membrane receptors in peripheral tissues: distribution and functions.
    Slominski RM; Reiter RJ; Schlabritz-Loutsevitch N; Ostrom RS; Slominski AT
    Mol Cell Endocrinol; 2012 Apr; 351(2):152-66. PubMed ID: 22245784
    [TBL] [Abstract][Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.